Oxford Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Oxford Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,128	Closed	-$674K	–	381
2023 Q4	$674K	Buy	+2,128	New	+$414K	1.01%	20
2019 Q4	–	Sell	-100,923	Closed	-$1.65M	–	2168
2019 Q3	$1.65M	Buy	100,923 +24,919	+33%	+$484K	0.04%	659
2019 Q2	$1.52M	Buy	+76,004	New	+$1.52M	0.03%	772

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Oxford Asset Management's KRTX Position: Q1 2024 in Review

Oxford Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,128 shares — an estimated $674K sold.

Oxford Asset Management first reported a position in KRTX in Q2 2019 and held it in 3 quarters. The position peaked at $1.65M in Q3 2019. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Oxford Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Oxford Asset Management sold 2,128 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $674K.
Oxford Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
Oxford Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.65M in Q3 2019.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.